LANSOPRAZOLE vs LAPATINIB DITOSYLATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LANSOPRAZOLE vs LAPATINIB DITOSYLATE: Safety Overview
| Metric | LANSOPRAZOLE | LAPATINIB DITOSYLATE |
|---|---|---|
| Total FAERS Reports | 60,931 | 3,948 |
| Deaths Reported | 6,896 | 921 |
| Death Rate | 11.3% | 23.3% |
| Hospitalizations | 12,277 | 752 |
| Average Patient Age | 60.3 yrs | 57.3 yrs |
| % Female Patients | 57.3% | 95.0% |
| FDA Approval Date | Apr 23, 2010 | Aug 16, 2024 |
| Manufacturer | Ascend Laboratories, LLC | AvKARE |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |